Evidence map›Paper›PMID 41853107›Full record

ArticleASM case reports2026

Ocular manifestations in a cohort of patients with mpox in the Democratic Republic of the Congo 2007-2011.

Placide Mbala-Kingebeni, Nam V Nguyen, Jean-Claude Mwanza, Jessica Carag, Susanne Linderman, Tolulope Fashina, Eddy Kinganda, Tony Wawina-Bokalanga, Amuri Aziza, Jean-Claude Makangara-Cigolo and 17 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ASM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Placide Mbala-Kingebeni *Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0003-1556-3570
Nam V Nguyen *Department of Ophthalmology, Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID https://orcid.org/0000-0003-3452-7612
Jean-Claude Mwanza *Department of Ophthalmology, University of North Carolina, Chapel Hill, North Carolina, USA.
Jessica CaragEmory University School of Medicine, Atlanta, Georgia, USA.
Susanne LindermanEmory University School of Medicine, Atlanta, Georgia, USA.
Tolulope FashinaDepartment of Ophthalmology, Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Eddy KingandaInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Tony Wawina-BokalangaInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Amuri AzizaInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Jean-Claude Makangara-CigoloInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Emmanuel Hasivirwe VakaniakiInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Yvon AntaInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Jepsy YangoInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Olivier TshianiInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
Jason KindrachukDepartment of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Laurens LiesenborghsDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Christophe Van DijckDepartment of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Martine PeetersTransVIHMI, Université de Montpellier, INSERM, IRD, Montpellier, France.
Eric DelaporteTransVIHMI, Université de Montpellier, INSERM, IRD, Montpellier, France.
Anne W RimoinDepartment of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California-Los Angeles, Los Angeles, California, USA.
John W HugginsDivision of Medicine, US Army Medical Institute of Infectious Diseases, Fort Detrick, Maryland, USA.
Therese Riu-RoviraHôpital Général de Référence de Kole, Kole-sur-Lukenie, Democratic Republic of the Congo.
Steve M AhukaInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
James W MartinRegional Health Command-Atlantic, Fort Belvoir, Virginia, USA.
Ian CrozierClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Steven YehDepartment of Ophthalmology, Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska, USA.ORCID https://orcid.org/0000-0002-5417-7771
Jean-Jacques MuyembeInstitut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.ORCID https://orcid.org/0000-0003-2933-818X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes the ocular manifestations in a cohort of patients with Clade I mpox evaluated in the Democratic Republic of the Congo from 2007 to 2011, as well as the clinical course of a 3-year-old patient with mpox associated with ocular disease. Among 216 patients, ocular manifestations were observed in 8.3%, including conjunctivitis, eyelid lesions, eyelid swelling, eye pain, orbital swelling, keratitis, and corneal staphyloma. These findings highlight the broad spectrum of ocular manifestations with potentially sight-threatening consequences in patients with mpox.

Indexed as

clade I monkeypox virusconjunctivitiscorneal staphylomaDemocratic Republic of the Congoeyelid edemakeratitismpoxocular manifestations

Identifiers

PMID41853107
PMCPMC12955382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.